Stay updated on Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated to v3.5.0 and previous revision v3.4.3 removed. This reflects a backend update to the page's versioning rather than changes to study data.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded the final published reference (Eur J Heart Fail, 2025) and removed the online-ahead-of-print citation for the study publications section.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.4.2 was added. The long notice about government funding lapses and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.5%

- Check77 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, including links to cc.nih.gov and opm.gov. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.